Approvals/TGA/CAVERJECT IMPULSE alprostadil 20microgram powder for injection with 0.5mL diluent dual chamber cartridge in single use syringe device

Approved

STANDARD

CAVERJECT IMPULSE alprostadil 20microgram powder for injection with 0.5mL diluent dual chamber cartridge in single use syringe device

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e8d20046f209288e
Product Name: CAVERJECT IMPULSE alprostadil 20microgram powder for injection with 0.5mL diluent dual chamber cartridge in single use syringe device
Artg Id: 90197
Artg Name: CAVERJECT IMPULSE alprostadil 20microgram powder for injection with 0.5mL diluent dual chamber cartridge in single use syringe device
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2002-07-29
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/0f83b5c712bc46b7da55b03966a773f9.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e07c73cf48a3aa1136713b42a426bc3f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e8d20046f209288e

Type

Standard